Insulet Corporation (PODD) PT Raised to $303 at Morgan Stanley
November 5, 2021 3:38 AM
Morgan Stanley analyst David Lewis raised the price target on Insulet Corporation (NASDAQ: PODD) to $303.00 (from $276.00) while maintaining a Equalweight rating.